Winner Medical Schedules 2008/2009 Full Year Earnings Release on Monday, December 7, 2009
(NYSE Amex: WWIN; “Winner Medical”, or the “Company”), today announced that it
will release its financial results for the year ended
The earnings release will be available on the investor relations page of
Winner Medical’s website athttp://ir.winnermedical.com on
2009
Following the earnings announcement, Winner Medical’s senior management
will host a conference call to discuss its 2008/09 full year results and
recent business developments.
Date of the conference call: Tuesday, December 8, 2009
Time: 5am (Pacific)/ 8am (Eastern)/ 9pm (Shenzhen/ Hong Kong)
Dial-in Number: 866-730-5762 (US)
10-800-130-0399 (South China)
10-800-152-1490 (North China)
800-96-3844 (HK)
1-857-350-1586 (International)
Passcode: 51709454.
A telephone replay will be available shortly after the conclusion of the
call and will be accessible through
(US) or +1-617-801-6888 (International); Passcode: 76372948.
About Winner Medical:
Winner Medical is a leading manufacturer and the largest exporter by
volume in the medical dressing industry in
the Company has seven wholly-owned operating subsidiaries and four joint-
ventures with over 5,000 employees. The Company engages in the manufacturing,
sale, research, and development of medical care products, wound care products,
home care products and PurCotton products, a nonwoven fabric made from 100%
natural cotton. The products are sold worldwide, with
States
holds more than sixty patents and patent applications for various products and
manufacturing processes and is one of the few Chinese companies licensed by
the U.S. Food and Drug Administration (FDA) to ship finished, sterilized
products directly to
Medical, please visit Winner Medical’s web site at
http://ir.winnermedical.com .
Forward-Looking Statements:
This press release contains certain statements that may include “forward-
looking statements” within the meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. All statements, other than statements of historical fact included
herein are “forward-looking statements” including statements regarding Winner
Medical and its subsidiary companies’ business strategy, plans and objective
and statements of non-historical information. These forward-looking
statements are often identified by the use of forward-looking terminology such
as “believes,” “expects” or similar expressions, involve known and unknown
risks and uncertainties. Although Winner Medical believes that the
expectations reflected in these forward-looking statements are reasonable,
they do involve assumptions, risks and uncertainties, and these expectations
may prove to be incorrect. You should not place undue reliance on these
forward-looking statements, which speak only as of the date of this press
release. Winner Medical’s actual results could differ materially from those
anticipated in these forward-looking statements as a result of a variety of
factors, including those discussed in Winner Medical’s periodic reports that
are filed with and available from the Securities and Exchange Commission. All
forward-looking statements attributable to Winner Medical or persons acting on
its behalf are expressly qualified in their entirety by these factors. Other
than as required under the securities laws, Winner Medical does not assume a
duty to update these forward-looking statements.
For more information, please contact:
Company:
Peng Zhai
Investor Relations Manager
Winner Medical Group Inc.
Tel: +86-755-2806-6858
+86-755-2813-8888 x691
Email: investors@winnermedical.com
Web: http://ir.winnermedical.com
Investors:
Mr. Matthew Hayden, HC International
Tel: +1-561-245-5155
Email: matt.hayden@hcinternational.net
Web: http://www.hcinternational.net
SOURCE Winner Medical Group Inc.
